Relationship of exercise capacity and left ventricular dimensions in patients with a normal ejection fraction. An exploratory study

PloS One
Markus MeyerMartin M LeWinter

Abstract

Extreme endurance exercise is known to be associated with an enlargement of the left ventricular (LV) chamber, whereas inactivity results in inverse changes. It is unknown if these dimensional relationships exist in patients. We analyzed the relationship of exercise capacity and LV dimension in a cohort of sequential patients with a normal ejection fraction undergoing stress echocardiography. In a total of 137 studies the following questions were addressed: (a) is there a difference in LV dimensions of patients with an excellent exercise capacity versus patients with a poor exercise capacity, (b) how is LV dimension and exercise capacity affected by LV wall thickness and (c) how do LV dimensions of patients who are unable to walk on a treadmill compare to the above groups. Patients with a poor exercise capacity or who are unable to physically exercise have a 34 percent smaller LV cavity size when compared to patients with an excellent exercise capacity (p<0.001). This reduction in LV chamber size is associated with concentric LV hypertrophy and a reciprocal increase in resting heart rate. In addition, cardiac output reserve is further blunted by chronotropic incompetence and a tachycardia-induced LV volume reduction. In conclus...Continue Reading

References

Jan 31, 1991·The New England Journal of Medicine·A PellicciaP Spirito
Feb 1, 1986·Circulation Research·M B HigginbothamF R Cobb
Jan 25, 2000·Circulation·B M PluimE E van der Wall
Jul 18, 2001·Journal of Applied Physiology·M A PerhonenB D Levine
Mar 1, 1960·The American Journal of Cardiology·A J LINZBACH
May 7, 2004·The New England Journal of Medicine·Michael R ZileWilliam H Gaasch
Jul 6, 2004·Journal of the American College of Cardiology·Eric AbergelJoël Menard
Sep 15, 2004·Circulation·Armin Arbab-ZadehBenjamin D Levine
Sep 4, 2007·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Patricia A PellikkaUNKNOWN American Society of Echocardiography
Mar 28, 2008·The New England Journal of Medicine·Joseph A Hill, Eric N Olson
Apr 17, 2008·Circulation·Dirk WestermannCarsten Tschöpe
Jan 22, 2009·JAMA : the Journal of the American Medical Association·Jasmine GrewalPatricia A Pellikka
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Jesús Peteiro, Alberto Bouzas-Mosquera
Jun 15, 2010·Circulation. Heart Failure·Barry A BorlaugMargaret M Redfield
Oct 20, 2010·Heart, Lung & Circulation·Jonathan P ChristiansenSaul G Myerson
Jul 2, 2011·Journal of the American College of Cardiology·Donald E SelbyMarkus Meyer
Oct 15, 2011·Journal of the American College of Cardiology·William H Gaasch, Michael R Zile
Nov 23, 2011·Circulation·James E Udelson
May 17, 2013·Circulation. Heart Failure·Jarett D BerryBenjamin Willis
Jul 24, 2013·Circulation·Gerald F FletcherUNKNOWN American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology,
Oct 15, 2013·BMC Cardiovascular Disorders·Mikkel Malby SchoosKasper Karmark Iversen
Jul 7, 2014·Journal of the American College of Cardiology·Emmy MandersCoen A C Ottenheijm
Jul 7, 2014·Journal of the American College of Cardiology·Markus Meyer

❮ Previous
Next ❯

Citations

Jul 18, 2015·Journal of Applied Physiology·Frank R HeinzelFrank Edelmann
Mar 20, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Patrícia G RodriguesInês Falcão-Pires
Sep 4, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Franziska J KleinMarkus Meyer
Apr 22, 2021·Journal of the American Heart Association·Daniel H Chen, Arjun K Ghosh

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.